查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403497

至 2030 年重症加護診斷市場預測：按產品、測試類型、最終用戶和地區分類的全球分析

Critical Care Diagnostics Market Forecasts to 2030 - Global Analysis By Product (Cancer Markers Testing Kit, Fecal Occult Testing Kits, Cholesterol Test Strips and Other Products), Test Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球重症加護診斷市場規模為 12.9 億美元，預計到 2030 年將達到 18.8 億美元，預測期內複合年成長率為 5.5%。

重症加護診斷旨在準確、快速地評估患有危及生命的疾病、需要立即治療的患者。該領域包括各種診斷程序和監測方法，旨在為醫療專業人員提供有關器官功能、血液氣體和電解質等重要參數的最新資料。在這一領域，快速且準確的診斷設備在監測和評估重症患者、實現有針對性的干涉以及改善患者整體治療效果方面發揮著重要作用。

根據美國醫學會的數據，美國在醫療保健上的支出為 4.3 兆美元，相當於每人 12,194 美元。同年衛生總支出約佔國內生產毛額的18.3%。

提高診斷意識

隨著世界各地的醫療保健系統認知到快速介入嚴重的重要性，人們越來越關注先進的診斷工具和技術。早期診斷使醫療保健專業人員能夠提供有針對性和及時的干涉措施，從而改善患者的預後並減少對醫療保健資源的整體需求。診斷技術的改進也推動了這一趨勢，從而帶來更快、更準確的測試方法。

發展中地區的可及性有限

全球重症加護診斷市場的一個主要障礙是新興市場的可近性較低。這些地區經常面臨診斷設施資源缺乏、技術純熟勞工缺乏以及醫療基礎設施不足等問題。結果，重症加護診斷的可近性和成本效益受到影響，阻礙了快速、準確的疾病診斷。然而，要規避這些限制並提高開發中國家重症患者診斷的可及性，解決這些問題的方法有很多，包括增加醫療基礎設施投資和強化能力建設項目，需要付出努力。

POCT 解決方案的需求不斷成長

對即時檢測 (POCT) 解決方案日益成長的需求正在為全球重症監護診斷市場創造重大機會。在緊急醫療領域，快速、準確的診斷結果變得越來越重要。 POCT 幫助醫療專業人員及時做出有關病患照護的決策。這一趨勢的推動因素是需要更快、更有效地診斷重症患者，以改善患者的治療結果。此外，先進分子檢測和攜帶式診斷設備等最尖端科技的引入也推動了市場成長。隨著全球醫療保健系統優先考慮高效提供重症加護，對創新診斷解決方案的需求不斷增加。

診斷技術日益複雜

開發尖端診斷技術的複雜性和成本不斷增加，對全球重症患者診斷市場構成嚴重威脅。隨著對更準確和更複雜的重症監護診斷的需求的增加，該行業面臨挑戰，包括與研發相關的成本、監管障礙以及對專業知識的需求。然而，醫療保健報銷和政策條件的變化可能會影響市場擴張，給製造商帶來挑戰，並抑制新診斷技術的採用。

COVID-19 的影響：

COVID-19大流行導致診斷器材與設備的需求激增。重症加護診斷技術透過快速、準確檢測的需求推動的創新和進步而取得了進展。分子診斷、影像解決方案和即時檢測設備的研發成本正在增加。重症患者，導致人們更加重視重症患者診斷解決方案。

懷孕和不孕症檢測套組領域預計將成為預測期內最大的市場。

妊娠和不孕症檢測套組領域預計將快速成長。懷孕和不孕症檢測套組套件部門專注於為測量和追蹤與懷孕和不孕症相關的參數而創建的診斷設備。這些檢測套組對於早期檢測懷孕和不孕症教育至關重要。這些測試使用血液和尿液分析等各種技術，提供準確的結果，以便進行計劃生育和及時干預。此外，自我監測趨勢的成長以及生殖健康意識的提高推動了對這些套件的需求。

預計微生物學和傳染病檢查領域在預測期內的複合年成長率最高。

由於對引起感染疾病的微生物病原體的識別和分析，微生物學和傳染病檢查領域預計將出現良好的成長。這個重要的領域測試各種檢體，如血液、尿液和組織樣本，以檢測細菌、病毒、真菌和寄生蟲。利用聚合酶鏈反應 (PCR) 和免疫檢測等先進的診斷技術，醫療保健專業人員可以快速、準確地診斷感染疾病。此外，分子技術和自動化的進步進一步提高了重症加護診斷中微生物和傳染病檢查檢測的效率和準確性。

比最大的地區

由於慢性病患病率上升和先進的醫療保健系統，北美地區的重症加護診斷市場正在顯著成長。呼吸系統疾病和心臟病等疾病的盛行率不斷增加，增加了對重症加護診斷的需求。該地區對早期疾病檢測和高醫療保健支出的重視正在推動重症加護診斷的成長。此外，北美深受強調及時診斷和治療重要性的政府舉措和宣傳宣傳活動的影響。

複合年成長率最高的地區：

由於人口高齡化以及嚴重監護環境中對快速準確診斷測試的需求等多種因素，歐洲地區正在經歷市場成長。已實施監管措施，確保重症加護診斷設備的品質、安全性和有效性，促進創新並推動區域成長。嚴格的核准流程和對高品質標準的遵守導致該行業的公司增加了研發投資。此外，在歐洲，我們繼續與主要產業參與者和學術機構合作，為重症患者的診斷提供支援。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球重症加護診斷市場：依產品

  • 癌症標記檢測套組
  • 大便潛血試驗套件
  • 膽固醇試紙
  • 藥物濫用檢測套組
  • 妊娠和生育力檢測套組
  • 心臟代謝監測套件
  • 傳染病檢查套件
  • 血糖監測套件
  • 其他產品

第6章全球重症加護診斷市場：依測試類型

  • 流式細胞儀
  • 血液學檢查
  • 血液凝固檢驗
  • 微生物學和傳染病檢查
  • 免疫蛋白
  • 日常化學和特殊化學
  • 其他測試類型

第7章全球重症加護診斷市場：依最終用戶分類

  • 手術室
  • 加護病房
  • 急診室
  • 其他最終用戶

第8章全球重症加護診斷市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Abbott Laboratories
  • Alere, Inc.
  • Bayer Healthcare AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • BioMerieux, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biosensors Japan Co., Ltd.
  • Chembio Diagnostic Systems, Inc.
  • EKF Diagnostics Holdings PLC
  • Nanomix, Inc.
  • Nova Biomedical Corporation
  • Roche Diagnostics AG
  • Siemens Healthineers
  • Sysmex Corporation
Product Code: SMRC24722

According to Stratistics MRC, the Global Critical Care Diagnostics Market is accounted for $1.29 billion in 2023 and is expected to reach $1.88 billion by 2030 growing at a CAGR of 5.5% during the forecast period. Critical care diagnostics is devoted to assessing patients accurately and quickly who have life-threatening illnesses that frequently call for immediate treatment. This area of study includes a variety of diagnostic procedures and monitoring methods intended to give medical professionals access to up-to-date data on critical parameters like organ function, blood gases, and electrolytes. In this field, quick and accurate diagnostic instruments play a major role in monitoring and assessing critically ill patients, enabling focused interventions, and enhancing overall patient outcomes.

According to America Medical Association, the U.S. spent USD 4.3 trillion on healthcare, which equates to USD 12,194 per capita. The overall health spending was around 18.3% of the GDP in the same year.

Market Dynamics:

Driver:

Increased awareness on diagnosis

An increasing focus is being placed on advanced diagnostic tools and technologies as healthcare systems across the globe acknowledge the significance of prompt intervention in critical conditions. Early diagnosis improves patient outcomes and lessens the overall demand on healthcare resources by allowing medical professionals to launch focused, timely interventions. Improvements in diagnostic techniques are also driving this trend, resulting in the creation of testing methods that are faster and more accurate.

Restraint:

Limited accessibility in developing regions

A major barrier to the global critical care diagnostics market is the lack of accessibility in developing nations. These areas frequently struggle with issues like a lack of resources for diagnostic facilities, a shortage of skilled workers, and inadequate healthcare infrastructure. Consequently, there are compromises in the accessibility and cost-effectiveness of critical care diagnostics, impeding prompt and precise disease diagnosis. However, to get around this restriction and enhance the accessibility of critical care diagnostics in developing nations, efforts must be made to address these issues, such as through increased investment in healthcare infrastructure and focused capacity-building programs.

Opportunity:

Growing demand for POCT solutions

The increasing need for point-of-care testing (POCT) solutions presents a major opportunity in the global critical care diagnostics market. In critical care settings, there is a growing focus on quick and accurate diagnostic results. POCT helps medical professionals make timely decisions about patient care. In order to improve patient outcomes, this trend is motivated by the need to expedite critical care diagnostics and increase their efficiency. The market's growth is also aided by the uptake of cutting-edge technologies like sophisticated molecular testing and portable diagnostic devices. Innovative diagnostic solutions are in high demand as global healthcare systems prioritize providing critical care efficiently.

Threat:

Increasing complexity associated with diagnostic technologies

The growing complexity and expense of creating cutting-edge diagnostic technologies pose a serious threat to the global critical care diagnostics market. The industry faces difficulties with regard to costs associated with research and development, obstacles posed by regulations, and the requirement for specialized knowledge as the demand for more accurate and sophisticated critical care diagnostics increases. However, changing healthcare reimbursement and policy landscapes may have an effect on market expansion, posing challenges for manufacturers and impeding the uptake of novel diagnostic technologies.

COVID-19 Impact:

The COVID-19 pandemic has caused a sharp increase in demand for diagnostic instruments and equipment. Critical care diagnostics technology has advanced due to innovation and advancements driven by the need for fast and accurate testing. Research and development expenditures for molecular diagnostics, imaging solutions, and point-of-care testing devices have increased. A greater emphasis on critical care diagnostic solutions has resulted from the pandemic's emphasis on the significance of early and accurate diagnostics in the management of critically ill patients.

The pregnancy and fertility testing kits segment is expected to be the largest during the forecast period

The pregnancy and fertility testing kits segment is estimated to grow at a rapid pace. The pregnancy and fertility testing kits segment focuses on diagnostic instruments made to measure and track parameters related to pregnancy and fertility. These kits are essential for early pregnancy detection and for educating people about their fertility. These tests, which use different techniques like blood or urine analysis, yield precise results that allow for family planning and prompt intervention. Additionally, the demand for these kits has been driven by the rising trend of self-monitoring along with increased awareness of reproductive health.

The microbiology and infectious test segment is expected to have the highest CAGR during the forecast period

The microbiology and infectious test segment is expected to hold lucrative growth as it identifies and analyzes microbial pathogens responsible for infectious diseases. This crucial segment involves the examination of various specimens, such as blood, urine, and tissue samples, to detect bacteria, viruses, fungi, and parasites. Utilizing advanced diagnostic technologies like polymerase chain reaction (PCR) and immunoassays, healthcare professionals can rapidly and accurately diagnose infectious conditions. Additionally, the ongoing advancements in molecular techniques and automation further enhance the efficiency and precision of microbiological and infectious tests in critical care diagnostics.

Region with largest share:

The market for critical care diagnostics has grown substantially in the North American region as a result of rising rates of chronic illness and sophisticated healthcare systems. The need for critical care diagnostics has increased due to the growing prevalence of illnesses like respiratory and cardiac disorders. The growth of critical care diagnostics has been facilitated by the region's emphasis on early disease detection and high healthcare spending. Moreover, North America has also been deeply influenced by government initiatives and awareness campaigns that highlight the significance of prompt diagnosis and treatment.

Region with highest CAGR:

The European region has experienced growth in the market as a result of various factors, including population aging, need for quick and precise diagnostic testing in critical care settings. Regulatory measures have been implemented to ensure the quality, safety, and efficacy of critical care diagnostic devices, fostering innovation and driving regional growth. Stringent approval processes and adherence to high-quality standards have led to increased investment in research and development by companies in the sector. In addition, partnerships between major industry participants and academic institutions and support for critical care diagnostics continued in Europe.

Key players in the market:

Some of the key players in Critical Care Diagnostics market include Abbott Laboratories, Alere, Inc., Bayer Healthcare AG, Beckman Coulter, Inc., Becton, Dickinson and Company, BioMerieux, Inc., Bio-Rad Laboratories, Inc., Biosensors Japan Co., Ltd., Chembio Diagnostic Systems, Inc., EKF Diagnostics Holdings PLC, Nanomix, Inc., Nova Biomedical Corporation, Roche Diagnostics AG, Siemens Healthineers and Sysmex Corporation.

Key Developments:

In December 2023, Fujirebio Holdings, Inc. and Sysmex Corporation announced that they have signed an agreement for the mutual supply of reagent raw materials owned by both companies. The Agreement is based on a basic agreement on business collaboration in the field of immunoassay*1 which the two companies signed.

In March 2023, ABEC announced it will provide customized, large-scale bioprocess equipment, including a 14,500-liter total volume stainless steel fermenter and an 8,000 liter media preparation system to EKF Life Sciences, a division of EKF Diagnostics Holdings plc. The agreement provides EKF Life Sciences' South Bend, Indiana facility with the bioprocess equipment which will significantly expand EKF's production capacity of enzymes used in a variety of diagnostic and Life Science applications.

Products Covered:

  • Cancer Markers Testing Kit
  • Fecal Occult Testing Kits
  • Cholesterol Test Strips
  • Drugs Of Abuse Testing Kits
  • Pregnancy and Fertility Testing Kits
  • Cardiometabolic Monitoring Kits
  • Infectious Disease Testing Kits
  • Glucose Monitoring Kits
  • Other Products

Test Types Covered:

  • Flow Cytometry
  • Hematology Test
  • Coagulation Test
  • Microbiology and Infectious Test
  • Immunoprotein
  • Routine and Special Chemistry
  • Other Test Types

End Users Covered:

  • Operating Room
  • Intensive Care Unit
  • Emergency Room
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Critical Care Diagnostics Market, By Product

  • 5.1 Introduction
  • 5.2 Cancer Markers Testing Kit
  • 5.3 Fecal Occult Testing Kits
  • 5.4 Cholesterol Test Strips
  • 5.5 Drugs Of Abuse Testing Kits
  • 5.6 Pregnancy and Fertility Testing Kits
  • 5.7 Cardiometabolic Monitoring Kits
  • 5.8 Infectious Disease Testing Kits
  • 5.9 Glucose Monitoring Kits
  • 5.10 Other Products

6 Global Critical Care Diagnostics Market, By Test Type

  • 6.1 Introduction
  • 6.2 Flow Cytometry
  • 6.3 Hematology Test
  • 6.4 Coagulation Test
  • 6.5 Microbiology and Infectious Test
  • 6.6 Immunoprotein
  • 6.7 Routine and Special Chemistry
  • 6.8 Other Test Types

7 Global Critical Care Diagnostics Market, By End User

  • 7.1 Introduction
  • 7.2 Operating Room
  • 7.3 Intensive Care Unit
  • 7.4 Emergency Room
  • 7.5 Other End Users

8 Global Critical Care Diagnostics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Alere, Inc.
  • 10.3 Bayer Healthcare AG
  • 10.4 Beckman Coulter, Inc.
  • 10.5 Becton, Dickinson and Company
  • 10.6 BioMerieux, Inc.
  • 10.7 Bio-Rad Laboratories, Inc.
  • 10.8 Biosensors Japan Co., Ltd.
  • 10.9 Chembio Diagnostic Systems, Inc.
  • 10.10 EKF Diagnostics Holdings PLC
  • 10.11 Nanomix, Inc.
  • 10.12 Nova Biomedical Corporation
  • 10.13 Roche Diagnostics AG
  • 10.14 Siemens Healthineers
  • 10.15 Sysmex Corporation

List of Tables

  • Table 1 Global Critical Care Diagnostics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 4 Global Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 5 Global Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 6 Global Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 7 Global Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 8 Global Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 9 Global Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 10 Global Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 11 Global Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 12 Global Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 13 Global Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 14 Global Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 15 Global Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 16 Global Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 17 Global Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 18 Global Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 19 Global Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 20 Global Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 21 Global Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 22 Global Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 23 Global Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 24 Global Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 North America Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 27 North America Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 28 North America Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 29 North America Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 30 North America Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 31 North America Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 32 North America Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 33 North America Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 34 North America Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 35 North America Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 36 North America Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 37 North America Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 38 North America Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 39 North America Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 40 North America Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 41 North America Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 42 North America Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 43 North America Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 44 North America Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 45 North America Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 46 North America Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 47 North America Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 48 North America Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 Europe Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 51 Europe Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 52 Europe Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 53 Europe Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 54 Europe Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 55 Europe Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 56 Europe Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 57 Europe Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 58 Europe Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 59 Europe Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 60 Europe Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 61 Europe Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 62 Europe Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 63 Europe Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 64 Europe Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 65 Europe Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 66 Europe Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 67 Europe Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 68 Europe Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 69 Europe Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 70 Europe Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 71 Europe Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 72 Europe Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 Asia Pacific Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 75 Asia Pacific Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 76 Asia Pacific Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 77 Asia Pacific Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 78 Asia Pacific Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 79 Asia Pacific Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 80 Asia Pacific Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 81 Asia Pacific Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 82 Asia Pacific Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 83 Asia Pacific Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 84 Asia Pacific Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 85 Asia Pacific Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 86 Asia Pacific Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 87 Asia Pacific Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 88 Asia Pacific Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 89 Asia Pacific Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 90 Asia Pacific Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 91 Asia Pacific Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 92 Asia Pacific Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 93 Asia Pacific Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 94 Asia Pacific Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 95 Asia Pacific Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 96 Asia Pacific Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 97 South America Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 99 South America Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 100 South America Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 101 South America Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 102 South America Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 103 South America Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 104 South America Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 105 South America Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 106 South America Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 107 South America Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 108 South America Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 109 South America Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 110 South America Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 111 South America Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 112 South America Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 113 South America Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 114 South America Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 115 South America Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 116 South America Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 117 South America Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 118 South America Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 119 South America Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 120 South America Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 121 Middle East & Africa Critical Care Diagnostics Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa Critical Care Diagnostics Market Outlook, By Product (2021-2030) ($MN)
  • Table 123 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cancer Markers Testing Kit (2021-2030) ($MN)
  • Table 124 Middle East & Africa Critical Care Diagnostics Market Outlook, By Fecal Occult Testing Kits (2021-2030) ($MN)
  • Table 125 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cholesterol Test Strips (2021-2030) ($MN)
  • Table 126 Middle East & Africa Critical Care Diagnostics Market Outlook, By Drugs Of Abuse Testing Kits (2021-2030) ($MN)
  • Table 127 Middle East & Africa Critical Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing Kits (2021-2030) ($MN)
  • Table 128 Middle East & Africa Critical Care Diagnostics Market Outlook, By Cardiometabolic Monitoring Kits (2021-2030) ($MN)
  • Table 129 Middle East & Africa Critical Care Diagnostics Market Outlook, By Infectious Disease Testing Kits (2021-2030) ($MN)
  • Table 130 Middle East & Africa Critical Care Diagnostics Market Outlook, By Glucose Monitoring Kits (2021-2030) ($MN)
  • Table 131 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 132 Middle East & Africa Critical Care Diagnostics Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 133 Middle East & Africa Critical Care Diagnostics Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 134 Middle East & Africa Critical Care Diagnostics Market Outlook, By Hematology Test (2021-2030) ($MN)
  • Table 135 Middle East & Africa Critical Care Diagnostics Market Outlook, By Coagulation Test (2021-2030) ($MN)
  • Table 136 Middle East & Africa Critical Care Diagnostics Market Outlook, By Microbiology and Infectious Test (2021-2030) ($MN)
  • Table 137 Middle East & Africa Critical Care Diagnostics Market Outlook, By Immunoprotein (2021-2030) ($MN)
  • Table 138 Middle East & Africa Critical Care Diagnostics Market Outlook, By Routine and Special Chemistry (2021-2030) ($MN)
  • Table 139 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 140 Middle East & Africa Critical Care Diagnostics Market Outlook, By End User (2021-2030) ($MN)
  • Table 141 Middle East & Africa Critical Care Diagnostics Market Outlook, By Operating Room (2021-2030) ($MN)
  • Table 142 Middle East & Africa Critical Care Diagnostics Market Outlook, By Intensive Care Unit (2021-2030) ($MN)
  • Table 143 Middle East & Africa Critical Care Diagnostics Market Outlook, By Emergency Room (2021-2030) ($MN)
  • Table 144 Middle East & Africa Critical Care Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)